![Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness](https://pub.mdpi-res.com/life/life-12-02050/article_deploy/html/images/life-12-02050-g001.png?1670482868)
Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
![Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness](https://www.mdpi.com/life/life-12-02050/article_deploy/html/images/life-12-02050-g002.png)
Life | Free Full-Text | Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
![A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies | BMC Dermatology | Full Text A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies | BMC Dermatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12895-019-0088-2/MediaObjects/12895_2019_88_Fig1_HTML.png)
A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies | BMC Dermatology | Full Text
![Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram](https://www.researchgate.net/profile/Sang-Woong-Youn/publication/283326359/figure/fig1/AS:614273302659079@1523465576302/Coverage-area-estimation-module-for-psoriasis-area-and-severity-index-body-surface_Q640.jpg)
Coverage area (%) estimation module for psoriasis area and severity... | Download Scientific Diagram
![Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2 - JDDonline - Journal of Drugs in Dermatology Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2 - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/article_3181/table1.jpg)
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2 - JDDonline - Journal of Drugs in Dermatology
Supplementary Table 1. Calculation of DAPSA and CPDAI and CPDAI disease activity categories (modified from [1,2]) Disease Activi
Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity
![PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol | The Journal of Rheumatology PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/45/7/922/F3.large.jpg)
PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol | The Journal of Rheumatology
![Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance | SpringerLink Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00435-2/MediaObjects/13555_2020_435_Fig2_HTML.png)
Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance | SpringerLink
![Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis](https://www.jhrr.org/articles/2018/5/2/images/JHealthResRev_2018_5_2_86_238863_i12.jpg)
Comparison of efficacy, safety, and cost-effectiveness of topical salicylic acid 6% versus clobetasol propionate 0.05% in the treatment of limited chronic plaque psoriasis
![Global Assessment of Psoriasis Severity and Change from Photographs: A Valid and Consistent Method - ScienceDirect Global Assessment of Psoriasis Severity and Change from Photographs: A Valid and Consistent Method - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022202X1534032X-gr3.gif)
Global Assessment of Psoriasis Severity and Change from Photographs: A Valid and Consistent Method - ScienceDirect
The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity
![POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS... POCKET.MD - Psoriasis Severity Calculator, PASI(Psoriasis Area Severity Index) is a measure of overall psoriasis severity and coverage, and BS...](http://www.pocket.md/images/appImages/screenshots/1384596010.jpeg)